Last 12 months
Inside the activity.
1 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 11, 2019 Filed Jul 15, 2019 20:30 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
SaleCommon Stock, No Par Value | 3,968 | $24.81 | $98,446.08 |
DisclosureSEC source: 0001127602-19-024534 · form4.xml · nonDerivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,722 F1 · kind: The sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:15 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Stock, No Par Value | 1,486 | $25.22 | $37,476.92 |
DisclosureSEC source: 0001127602-19-023539 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,014 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:22 UTC |
WECHSLER AMY BDirector
|
GrantCommon Stock, No Par Value | 1,263 | $25.22 | $31,852.86 |
DisclosureSEC source: 0001127602-19-023546 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,351 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:12 UTC |
Paulson JohnDirector
|
GrantCommon Stock, No Par Value | 1,090 | $25.22 | $27,489.80 |
DisclosureSEC source: 0001127602-19-023537 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,535 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:11 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Stock, No Par Value | 1,239 | $25.22 | $31,247.58 |
DisclosureSEC source: 0001127602-19-023535 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,776 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:17 UTC |
McKenna Mark C.President, Salix
|
Tax withholdingCommon Shares, No Par Value | 1,913 | $23.82 | $45,567.66 |
DisclosureSEC source: 0001127602-19-022856 · form4.xml · nonDerivative · entry 1 McKenna Mark C. · CIK 0001749623 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,529 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 21:19 UTC |
ValueAct Holdings, L.P.Director · See Remarks
ValueAct Holdings II, L.P.Director · See Remarks
ValueAct Capital Master Fund, L.P.Director · See Remarks
ValueAct Co-Invest Master Fund, L.P.Director · See Remarks
VA Partners I, LLCDirector · See Remarks
ValueAct Capital Management, L.P.Director · See Remarks
ValueAct Capital Management, LLCDirector · See Remarks
ValueAct Holdings GP, LLCDirector · See Remarks
|
OtherCommon Shares, no par value | 111,440 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001418812-19-000039 · primary_doc.xml · nonDerivative · entry 1 ValueAct Holdings, L.P. · CIK 0001418814 · Director · See Remarks ValueAct Holdings II, L.P. · CIK 0001763309 · Director · See Remarks ValueAct Capital Master Fund, L.P. · CIK 0001464912 · Director · See Remarks ValueAct Co-Invest Master Fund, L.P. · CIK 0001579734 · Director · See Remarks VA Partners I, LLC · CIK 0001418812 · Director · See Remarks ValueAct Capital Management, L.P. · CIK 0001351069 · Director · See Remarks ValueAct Capital Management, LLC · CIK 0001351073 · Director · See Remarks ValueAct Holdings GP, LLC · CIK 0001418813 · Director · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 948,353 F1 · kind: Represents an in-kind pro rata distribution of Common Stock of the Issuer without consideration by ValueAct Co-Invest Master Fund, L.P. ("Co-Invest Fund") to return capital to a limited partner in the Co-Invest Fund. F1 · price: Represents an in-kind pro rata distribution of Common Stock of the Issuer without consideration by ValueAct Co-Invest Master Fund, L.P. ("Co-Invest Fund") to return capital to a limited partner in the Co-Invest Fund. F2 · ownership.nature: Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F3 · ownership.nature: The securities reported herein are directly beneficially owned by Co-Invest Fund and may be deemed to be indirectly beneficially owned by (i) VA Partners I, LLC as General Partner of Co-Invest Fund, (ii) ValueAct Capital Management, L.P. as the manager of Co-Invest Fund, (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the majority owner of the membership interests of VA Partners I, LLC, (v) ValueAct Holdings II, L.P. as the sole owner of the membership interests of ValueAct Capital Management, LLC and as the majority owner of the limited partnership interests of ValueAct Capital Management, L.P., and (vi) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. and ValueAct Holdings II, L.P. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 20:14 UTC |
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER
|
Tax withholdingCommon Stock, No Par Value | 6,370 | $20.73 | $132,050.10 |
DisclosureSEC source: 0001127602-19-021018 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,444 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:25 UTC |
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l
|
Tax withholdingCommon Shares, No Par Value | 693 | $23.51 | $16,292.43 |
DisclosureSEC source: 0001127602-19-017751 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,196 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:16 UTC |
McKenna Mark C.President, Salix
|
Tax withholdingCommon Shares, No Par Value | 746 | $23.51 | $17,538.46 |
DisclosureSEC source: 0001127602-19-017744 · form4.xml · nonDerivative · entry 1 McKenna Mark C. · CIK 0001749623 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,442 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:15 UTC |
KAVANAGH SARAH BDirector
|
GrantCommon Stock, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017264 · form4.xml · nonDerivative · entry 1 KAVANAGH SARAH B · CIK 0001681171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,378 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:19 UTC |
Ross Thomas W. Sr.Director
|
GrantCommon Stock, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017271 · form4.xml · nonDerivative · entry 1 Ross Thomas W. Sr. · CIK 0001669396 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,802 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:17 UTC |
POWER ROBERT NDirector
|
GrantCommon Stock, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017267 · form4.xml · nonDerivative · entry 1 POWER ROBERT N · CIK 0001187303 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,742 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| May 03, 2019 Filed May 3, 2019 21:46 UTC |
Hale David RobertDirector · See Remarks
ValueAct Holdings, L.P.Director · See Remarks
ValueAct Capital Master Fund, L.P.Director · See Remarks
ValueAct Co-Invest Master Fund, L.P.Director · See Remarks
VA Partners I, LLCDirector · See Remarks
ValueAct Capital Management, L.P.Director · See Remarks
ValueAct Capital Management, LLCDirector · See Remarks
ValueAct Holdings II, L.P.Director · See Remarks
ValueAct Holdings GP, LLCDirector · See Remarks
|
GrantCommon Stock, no par value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001418812-19-000025 · primary_doc.xml · nonDerivative · entry 2 Hale David Robert · CIK 0001635643 · Director · See Remarks ValueAct Holdings, L.P. · CIK 0001418814 · Director · See Remarks ValueAct Capital Master Fund, L.P. · CIK 0001464912 · Director · See Remarks ValueAct Co-Invest Master Fund, L.P. · CIK 0001579734 · Director · See Remarks VA Partners I, LLC · CIK 0001418812 · Director · See Remarks ValueAct Capital Management, L.P. · CIK 0001351069 · Director · See Remarks ValueAct Capital Management, LLC · CIK 0001351073 · Director · See Remarks ValueAct Holdings II, L.P. · CIK 0001763309 · Director · See Remarks ValueAct Holdings GP, LLC · CIK 0001418813 · Director · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,518 F4 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health(the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. F2 · ownership.direct: All board compensation accrues to the benefit of the investors in ValueAct Capital Master Fund, L.P., and not to any individual. Under an agreement with ValueAct Capital, D. Robert Hale is deemed to hold the restricted share units for the benefit of the limited partners of ValueAct Capital Master Fund, L.P. and indirectly for (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the sole owner of the limited partnership interests of ValueAct Capital Management, L.P. and the membership interests of ValueAct Capital Management, LLC and as the majority owner of the membership interests of VA Partners I, LLC and (v) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. F3 · ownership.direct: Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:21 UTC |
WECHSLER AMY BDirector
|
GrantCommon Stock, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017275 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,088 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:20 UTC |
VON ESCHENBACH ANDREW C.Director
|
GrantCommon Shares, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017273 · form4.xml · nonDerivative · entry 1 VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,465 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:18 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Stock, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017268 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,528 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:16 UTC |
Paulson JohnDirector
|
GrantCommon Stock, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017266 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,445 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:14 UTC |
KARABELAS ARGERIS NDirector
|
GrantCommon Stock, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017262 · form4.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,646 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:13 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Stock, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017259 · form4.xml · nonDerivative · entry 2 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,537 F2 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| May 01, 2019 Filed May 3, 2019 21:46 UTC |
Hale David RobertDirector · See Remarks
ValueAct Holdings, L.P.Director · See Remarks
ValueAct Capital Master Fund, L.P.Director · See Remarks
ValueAct Co-Invest Master Fund, L.P.Director · See Remarks
VA Partners I, LLCDirector · See Remarks
ValueAct Capital Management, L.P.Director · See Remarks
ValueAct Capital Management, LLCDirector · See Remarks
ValueAct Holdings II, L.P.Director · See Remarks
ValueAct Holdings GP, LLCDirector · See Remarks
|
Tax withholdingCommon Stock, no par value | 3,996 | $23.63 | $94,425.48 |
DisclosureSEC source: 0001418812-19-000025 · primary_doc.xml · nonDerivative · entry 1 Hale David Robert · CIK 0001635643 · Director · See Remarks ValueAct Holdings, L.P. · CIK 0001418814 · Director · See Remarks ValueAct Capital Master Fund, L.P. · CIK 0001464912 · Director · See Remarks ValueAct Co-Invest Master Fund, L.P. · CIK 0001579734 · Director · See Remarks VA Partners I, LLC · CIK 0001418812 · Director · See Remarks ValueAct Capital Management, L.P. · CIK 0001351069 · Director · See Remarks ValueAct Capital Management, LLC · CIK 0001351073 · Director · See Remarks ValueAct Holdings II, L.P. · CIK 0001763309 · Director · See Remarks ValueAct Holdings GP, LLC · CIK 0001418813 · Director · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,885 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. F2 · ownership.direct: All board compensation accrues to the benefit of the investors in ValueAct Capital Master Fund, L.P., and not to any individual. Under an agreement with ValueAct Capital, D. Robert Hale is deemed to hold the restricted share units for the benefit of the limited partners of ValueAct Capital Master Fund, L.P. and indirectly for (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the sole owner of the limited partnership interests of ValueAct Capital Management, L.P. and the membership interests of ValueAct Capital Management, LLC and as the majority owner of the membership interests of VA Partners I, LLC and (v) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. F3 · ownership.direct: Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:13 UTC |
DE SCHUTTER RICHARD UDirector
|
Tax withholdingCommon Stock, No Par Value | 3,996 | $23.63 | $94,425.48 |
DisclosureSEC source: 0001127602-19-017259 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,904 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 29, 2019 Filed Apr 3, 2019 21:04 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Stock, No Par Value | 1,518 | $24.70 | $37,494.60 |
DisclosureSEC source: 0001127602-19-014685 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,895 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 29, 2019 Filed Apr 3, 2019 21:08 UTC |
WECHSLER AMY BDirector
|
GrantCommon Stock, No Par Value | 1,290 | $24.70 | $31,863.00 |
DisclosureSEC source: 0001127602-19-014693 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,455 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 29, 2019 Filed Apr 3, 2019 20:55 UTC |
Paulson JohnDirector
|
GrantCommon Stock, No Par Value | 1,113 | $24.70 | $27,491.10 |
DisclosureSEC source: 0001127602-19-014668 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,812 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 29, 2019 Filed Apr 3, 2019 20:47 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Stock, No Par Value | 1,265 | $24.70 | $31,245.50 |
DisclosureSEC source: 0001127602-19-014648 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,900 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:40 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
Tax withholdingCommon Shares, No Par Value | 18,658 | $23.56 | $439,582.48 |
DisclosureSEC source: 0001127602-19-011053 · form4.xml · nonDerivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 809,601 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:38 UTC |
McKenna Mark C.President, Salix
|
Tax withholdingCommon Shares, No Par Value | 974 | $23.56 | $22,947.44 |
DisclosureSEC source: 0001127602-19-011050 · form4.xml · nonDerivative · entry 1 McKenna Mark C. · CIK 0001749623 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,188 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:31 UTC |
Herendeen PaulEVP and CFO
|
Tax withholdingCommon Stock, No Par Value | 9,796 | $23.56 | $230,793.76 |
DisclosureSEC source: 0001127602-19-011040 · form4.xml · nonDerivative · entry 1 Herendeen Paul · CIK 0001374175 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,985 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:28 UTC |
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l
|
Tax withholdingCommon Shares, No Par Value | 1,557 | $23.56 | $36,682.92 |
DisclosureSEC source: 0001127602-19-011034 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,889 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:27 UTC |
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER
|
Tax withholdingCommon Stock, No Par Value | 1,217 | $23.56 | $28,672.52 |
DisclosureSEC source: 0001127602-19-011032 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,814 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:25 UTC |
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l
|
Tax withholdingCommon Stock, No Par Value | 2,907 | $23.56 | $68,488.92 |
DisclosureSEC source: 0001127602-19-011029 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,043 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:17 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
Tax withholdingCommon Stock, No Par Value | 3,630 | $23.56 | $85,522.80 |
DisclosureSEC source: 0001127602-19-011019 · form4.xml · nonDerivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,690 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 28, 2019 Filed Feb 28, 2019 21:10 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
GrantCommon Shares, No Par Value | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-008918 · form4.xml · nonDerivative · entry 2 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 747,077 Read SEC document |
| February 28, 2019 Filed Feb 28, 2019 21:10 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
PurchaseCommon Shares, No Par Value | 30,000 | $23.67 | $710,100.00 |
DisclosureSEC source: 0001127602-19-008918 · form4.xml · nonDerivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 717,077 F1 · shares: Represents matching Restricted Share Units ("MRSUs") granted to the Reporting Person in connection with the open market purchase of Common Shares of the Issuer reported on Table I (the "Purchased Shares"), pursuant to the Issuer's Matching Share Program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant ("MRSU Grant Date"), subject to the Reporting Person's continued service (except in limited circumstances). Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:14 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 236,183 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001127602-19-009258 · form4.xml · derivative · entry 2 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,183 Underlying: Common Shares, No Par Value · 236,183 shares Expires 2029-02-27 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:14 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
GrantCommon Shares, No Par Value | 81,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009258 · form4.xml · nonDerivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 768,259 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health"). Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:13 UTC |
McKenna Mark C.President, Salix
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 44,290 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001127602-19-009255 · form4.xml · derivative · entry 2 McKenna Mark C. · CIK 0001749623 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,290 Underlying: Common Shares, No Par Value · 44,290 shares Expires 2029-02-27 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:13 UTC |
McKenna Mark C.President, Salix
|
GrantCommon Shares, No Par Value | 15,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009255 · form4.xml · nonDerivative · entry 1 McKenna Mark C. · CIK 0001749623 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,162 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health"). Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:11 UTC |
Humphries William D.President, Ortho-Dermatologics
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 44,290 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001127602-19-009252 · form4.xml · derivative · entry 2 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,290 Underlying: Common Shares, No Par Value · 44,290 shares Expires 2029-02-27 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:11 UTC |
Humphries William D.President, Ortho-Dermatologics
|
GrantCommon Stock, No Par Value | 15,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009252 · form4.xml · nonDerivative · entry 1 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,018 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health"). Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:09 UTC |
Herendeen PaulEVP and CFO
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 124,002 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001127602-19-009246 · form4.xml · derivative · entry 2 Herendeen Paul · CIK 0001374175 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,002 Underlying: Common Shares, No Par Value · 124,002 shares Expires 2029-02-27 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:09 UTC |
Herendeen PaulEVP and CFO
|
GrantCommon Stock, No Par Value | 62,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009246 · form4.xml · nonDerivative · entry 1 Herendeen Paul · CIK 0001374175 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,781 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health"). Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:06 UTC |
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 44,290 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001127602-19-009243 · form4.xml · derivative · entry 2 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,290 Underlying: Common Shares, No Par Value · 44,290 shares Expires 2029-02-27 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:06 UTC |
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l
|
GrantCommon Shares, No Par Value | 15,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009243 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,446 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health"). Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:04 UTC |
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 22,149 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001127602-19-009240 · form4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,149 Underlying: Common Shares, No Par Value · 22,149 shares Expires 2029-02-27 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:04 UTC |
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER
|
GrantCommon Stock, No Par Value | 7,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009240 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,031 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health"). Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 21:57 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 62,004 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001127602-19-009227 · form4.xml · derivative · entry 2 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,004 Underlying: Common Shares, No Par Value · 62,004 shares Expires 2029-02-27 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 21:57 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
GrantCommon Stock, No Par Value | 21,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009227 · form4.xml · nonDerivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,320 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health"). Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:01 UTC |
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 62,004 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001127602-19-009234 · form4.xml · derivative · entry 2 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,004 Underlying: Common Shares, No Par Value · 62,004 shares Expires 2029-02-27 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.